1. Zhao M, Veeranki SP, Magnussen CG, Xi B. Recommended physical activity and all cause and cause specific mortality in US adults: prospective cohort study. BMJ. 2020; 370:m2031. PMID:
32611588.
2. Lee SW, Lee J, Moon SY, Jin HY, Yang JM, Ogino S, et al. Physical activity and the risk of SARS-CoV-2 infection, severe COVID-19 illness and COVID-19 related mortality in South Korea: a nationwide cohort study. Br J Sports Med. 2022; 56(16):901–912. PMID:
34301715.
3. Bull FC, Al-Ansari SS, Biddle S, Borodulin K, Buman MP, Cardon G, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020; 54(24):1451–1462. PMID:
33239350.
4. Sawalla Guseh J, Lieberman D, Baggish A. The evidence for exercise in medicine - a new review series. NEJM Evid. 2022; 1(3):EVIDra2100002. PMID:
38319204.
5. Chekroud SR, Gueorguieva R, Zheutlin AB, Paulus M, Krumholz HM, Krystal JH, et al. Association between physical exercise and mental health in 1·2 million individuals in the USA between 2011 and 2015: a cross-sectional study. Lancet Psychiatry. 2018; 5(9):739–746. PMID:
30099000.
6. Sun X, Yon DK, Nguyen TT, Tanisawa K, Son K, Zhang L, et al. Dietary and other lifestyle factors and their influence on non-communicable diseases in the Western Pacific region. Lancet Reg Health West Pac. 2023; 43:100842. PMID:
38456094.
7. GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023; 402(10397):203–234. PMID:
37356446.
8. Park S, Lee H, Cho W, Woo HG, Lim H, Kim S, et al. Efficacy of information and communication technology interventions for the management of diabetes mellitus: an umbrella review and evidence map. Obes Rev. 2024; 25(5):e13714. PMID:
38350665.
9. O’Hearn M, Lara-Castor L, Cudhea F, Miller V, Reedy J, Shi P, et al. Incident type 2 diabetes attributable to suboptimal diet in 184 countries. Nat Med. 2023; 29(4):982–995. PMID:
37069363.
10. Huh Y, Kim SH, Nam GE, Park HS. Weight gain, comorbidities, and its associated factors among Korean adults. J Korean Med Sci. 2023; 38(12):e90. PMID:
36974399.
11. Lim Y, Kim HJ, Yoon SS, Lee SJ, Lee MH, Park H, et al. Exercise frequency reduction is associated with higher risk of infection in newly diagnosed diabetes: a nationally representative cohort study. J Korean Med Sci. 2023; 38(23):e176. PMID:
37309695.
12. Mukherji AB, Lu D, Qin F, Hedlin H, Johannsen NM, Chung S, et al. Effectiveness of a community-based structured physical activity program for adults with type 2 diabetes: a randomized clinical trial. JAMA Netw Open. 2022; 5(12):e2247858. PMID:
36542382.
13. Kang MG, Kim OS, Hoogendijk EO, Jung HW. Trends in frailty prevalence among older adults in Korea: a nationwide study from 2008 to 2020. J Korean Med Sci. 2023; 38(29):e157. PMID:
37489714.
14. Park S, Kim HJ, Kim S, Rhee SY, Woo HG, Lim H, et al. National trends in physical activity among adults in South Korea before and during the COVID-19 pandemic, 2009–2021. JAMA Netw Open. 2023; 6(6):e2316930. PMID:
37273204.
15. Lee EW, Park JH. Individual and socioeconomic contextual effects on depressive symptom in Korea: multilevel analysis of cross-sectional nationwide survey. J Korean Med Sci. 2015; 30(2):186–193. PMID:
25653491.
16. Kang YW, Ko YS, Kim YJ, Sung KM, Kim HJ, Choi HY, et al. Korea community health survey data profiles. Osong Public Health Res Perspect. 2015; 6(3):211–217. PMID:
26430619.
17. Oh J, Kim S, Lee M, Rhee SY, Kim MS, Shin JY, et al. National and regional trends in the prevalence of type 2 diabetes and associated risk factors among Korean adults, 2009–2021. Sci Rep. 2023; 13(1):16727. PMID:
37794087.
18. Yoo IK, Marshall DC, Cho JY, Yoo HW, Lee SW. N-nitrosodimethylamine-contaminated ranitidine and risk of cancer in South Korea: a nationwide cohort study. Life Cycle. 2021; 1:e1.
19. Lee H, Cho JK, Park J, Lee H, Fond G, Boyer L, et al. Machine learning-based prediction of suicidality in adolescents with allergic rhinitis: derivation and validation in 2 independent nationwide cohorts. J Med Internet Res. 2024; 26:e51473. PMID:
38354043.
20. Ho FK, Zhou Z, Petermann-Rocha F, Para-Soto S, Boonpor J, Welsh P, et al. Association between device-measured physical activity and incident heart failure: a prospective cohort study of 94 739 UK biobank participants. Circulation. 2022; 146(12):883–891. PMID:
36036153.
21. Dos Santos M, Ferrari G, Lee DH, Rey-López JP, Aune D, Liao B, et al. Association of the “weekend warrior” and other leisure-time physical activity patterns with all-cause and cause-specific mortality: a nationwide cohort study. JAMA Intern Med. 2022; 182(8):840–848. PMID:
35788615.
22. O’Donovan G, Lee IM, Hamer M, Stamatakis E. Association of “weekend warrior” and other leisure time physical activity patterns with risks for all-cause, cardiovascular disease, and cancer mortality. JAMA Intern Med. 2017; 177(3):335–342. PMID:
28097313.
23. Khurshid S, Al-Alusi MA, Churchill TW, Guseh JS, Ellinor PT. Accelerometer-derived “weekend warrior” physical activity and incident cardiovascular disease. JAMA. 2023; 330(3):247–252. PMID:
37462704.
24. Kang J, Kim HJ, Kim T, Lee H, Kim M, Lee SW, et al. Prenatal opioid exposure and subsequent risk of neuropsychiatric disorders in children: nationwide birth cohort study in South Korea. BMJ. 2024; 385:e077664. PMID:
38658035.
25. Yoo HW, Jin HY, Yon DK, Effenberger M, Shin YH, Kim SY, et al. Non-alcoholic fatty liver disease and COVID-19 susceptibility and outcomes: a Korean nationwide cohort. J Korean Med Sci. 2021; 36(41):e291. PMID:
34697932.
26. Fang M, Selvin E. Thirty-year trends in complications in U.S. adults with newly diagnosed type 2 diabetes. Diabetes Care. 2021; 44(3):699–706. PMID:
33419932.
27. Macek P, Terek-Derszniak M, Zak M, Biskup M, Ciepiela P, Krol H, et al. WHO recommendations on physical activity versus compliance rate within a specific urban population as assessed through IPAQ survey: a cross-sectional cohort study. BMJ Open. 2019; 9(6):e028334.
28. Wasfy MM, Lee IM. Examining the dose-response relationship between physical activity and health outcomes. NEJM Evid. 2022; 1(12):EVIDra2200190. PMID:
38319830.
29. Piché ME, Tchernof A, Després JP. Obesity phenotypes, diabetes, and cardiovascular diseases. Circ Res. 2020; 126(11):1477–1500. PMID:
32437302.
30. Joseph JJ, Golden SH. Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus. Ann N Y Acad Sci. 2017; 1391(1):20–34. PMID:
27750377.
31. Bhatt S, Nagappa AN, Patil CR. Role of oxidative stress in depression. Drug Discov Today. 2020; 25(7):1270–1276. PMID:
32404275.
32. Cho MR, Lee S, Song SK. A review of sarcopenia pathophysiology, diagnosis, treatment and future direction. J Korean Med Sci. 2022; 37(18):e146. PMID:
35535373.
33. Radak Z, Chung HY, Goto S. Systemic adaptation to oxidative challenge induced by regular exercise. Free Radic Biol Med. 2008; 44(2):153–159. PMID:
18191751.
34. Boakye K, Bovbjerg M, Schuna J Jr, Branscum A, Varma RP, Ismail R, et al. Urbanization and physical activity in the global prospective urban and rural epidemiology study. Sci Rep. 2023; 13(1):290. PMID:
36609613.
35. Gong P, Liang S, Carlton EJ, Jiang Q, Wu J, Wang L, et al. Urbanisation and health in China. Lancet. 2012; 379(9818):843–852. PMID:
22386037.
36. Ahmadi MN, Hamer M, Gill JM, Murphy M, Sanders JP, Doherty A, et al. Brief bouts of device-measured intermittent lifestyle physical activity and its association with major adverse cardiovascular events and mortality in people who do not exercise: a prospective cohort study. Lancet Public Health. 2023; 8(10):e800–e810. PMID:
37777289.
37. Jacob L, Gyasi RM, Oh H, Smith L, Kostev K, López Sánchez GF, et al. Leisure-time physical activity and sarcopenia among older adults from low- and middle-income countries. J Cachexia Sarcopenia Muscle. 2023; 14(2):1130–1138. PMID:
36872652.
38. Scott SN, Fontana FY, Cocks M, Morton JP, Jeukendrup A, Dragulin R, et al. Post-exercise recovery for the endurance athlete with type 1 diabetes: a consensus statement. Lancet Diabetes Endocrinol. 2021; 9(5):304–317. PMID:
33864810.